Glucarpidase for treatment of high-dose methotrexate toxicity
Shruti Gupta(Harvard University), Anthony Nicolaysen(University of California, Los Angeles), Daniel Edmonston(Duke University), Javier A. Neyra(University of Alabama at Birmingham), C. John Sperati(Johns Hopkins University), Huong L. Truong(Mayo Clinic), M. Salman Sheikh(Mayo Clinic), Anushree C. Shirali(Medical Protective), Amanda D. Renaghan(University of Virginia Health System), Swetha Rani Kanduri(The University of Texas at San Antonio Health Science Center), Jonathan Jakubowski(Washington University in St. Louis), Bradley Yelvington(Vanderbilt University Medical Center), Arash Rashidi(University Hospitals of Cleveland), Christopher A. Carlos(University of California, San Francisco), John T. Patton(The Ohio State University), Zain Mithani(University of Miami), Katherine J. Kelly(Indiana University School of Medicine), Jason N. Barreto(Mayo Clinic), Dasol Kang(University of Ulsan), Ala Abudayyeh(The University of Texas MD Anderson Cancer Center), Sarah Wall(The Ohio State University), David A. Bond(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Christopher J. Passero(University of Pittsburgh), Ilya Glezerman(Memorial Sloan Kettering Cancer Center), Jason Prosek(The Ohio State University), Nicholas Lucchesi(University of Virginia Health System), Anthony C. Wood(Moffitt Cancer Center), Julie‐Alexia Dias(Harvard University), Arun Rajasekaran(University of Alabama at Birmingham), Daniel Sanghoon Shin(Michael E. DeBakey VA Medical Center), Rachid Baz(Moffitt Cancer Center), Chintan V. Shah(University of Florida), Kevin L. Chen(Harvard University), Ashwini Pujari(University of Alabama at Birmingham), Claude Bassil(Moffitt Cancer Center), Jan Drappatz(University of Pittsburgh), Susan Ziolkowski(Palo Alto University), Sarah Allison Kaunfer(Brigham and Women's Hospital), Jingjing Zhang(Nanjing University), Sandra M. Herrmann(Mayo Clinic), Anip Bansal(University of Colorado Anschutz Medical Campus), Muhammad Ahsan Rasheed(Thomas Jefferson University), Anitha Vijayan, Emily Dotson(The Ohio State University), Raymond K. Hsu(University of California, San Francisco), Michael David Kolman(Rush University Medical Center), Abdallah Sassine Geara(University of Pennsylvania)
Cited by 30
Related Papers
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
|New England Journal of Medicine|2008|1.8k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury.
|Journal of Clinical Investigation|1996|730
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
|Nature Reviews Nephrology|2020|703
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555